|
127 Companies |
|
139 Products |
|
139 Products |
|
89 Mechanisms of Action |
|
9 Trials |
|
1220 News |
|
| «12...1314151617181920212223...2425» |
- ||| Enrollment closed: Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia (clinicaltrials.gov) - Jul 21, 2013
P4, N=140, Active, not recruiting, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting
- ||||| Erbitux (cetuximab) / Eli Lilly
New P2 trial: Cetuximab, Paclitaxel, Carboplatin And Radiation For Esophageal, Gastroesophageal Junction And Gastric Cancer (clinicaltrials.gov) - Jul 18, 2013
P2, N=60, Completed, Sponsor: Brown University
- azithromycin / Generic mfg.
Trial termination: Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis (clinicaltrials.gov) - Jul 15, 2013
P2, N=37, Terminated, Sponsor: University of Florida
Recruiting --> Active, not recruiting Active, not recruiting --> Terminated; Original investigator left this institution, replacement investigator retired.
- azithromycin / Generic mfg.
Enrollment change: Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis (clinicaltrials.gov) - Jul 15, 2013
P2, N=37, Terminated, Sponsor: University of Florida
Active, not recruiting --> Terminated; Original investigator left this institution, replacement investigator retired. N=50 --> 37
- cabazitaxel / Generic mfg.
Enrollment change, Metastases: GASTANA: Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy (clinicaltrials.gov) - Jul 14, 2013
P1, N=16, Completed, Sponsor: Sanofi
N=50 --> 37 N=45 --> 16
- | cabazitaxel / Generic mfg.
Trial completion, Metastases: GASTANA: Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior Chemotherapy (clinicaltrials.gov) - Jul 14, 2013
P1, N=16, Completed, Sponsor: Sanofi
N=45 --> 16 Recruiting --> Completed
- Enrollment open: Her 2 Testing in Indian Patients With Gastric Cancer (clinicaltrials.gov) - Jul 9, 2013
P=N/A, N=100, Recruiting, Sponsor: Tata Memorial Hospital
Recruiting --> Completed Active, not recruiting --> Recruiting
- || Herceptin (trastuzumab) / Roche
Enrollment change: An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer (clinicaltrials.gov) - Jul 8, 2013
P=N/A, N=443, Active, not recruiting, Sponsor: Hoffmann-La Roche
Active, not recruiting --> Recruiting N=1500 --> 443
- Signifor (pasireotide) / Recordati
New P2 trial: Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome (clinicaltrials.gov) - Jul 8, 2013
P2, N=9, Completed, Sponsor: Universitaire Ziekenhuizen Leuven
- || Herceptin (trastuzumab) / Roche
Enrollment closed: An Observational Study of Herceptin (Trastuzumab) in Patients With HER2-positive Advanced Gastric Cancer (clinicaltrials.gov) - Jul 8, 2013
P=N/A, N=443, Active, not recruiting, Sponsor: Hoffmann-La Roche
N=1500 --> 443 Recruiting --> Active, not recruiting
- |||| Trial completion: To Evaluate the Efficacy and Safety of Vitamin B12 Contains Extract of Lamb's Stomach in Treatment of Chronic Atrophic Gastritis (CAG) (clinicaltrials.gov) - Jul 5, 2013
P4, N=851, Completed, Sponsor: Xinjiang Biochemical Pharmaceutical Co., Ltd.
Recruiting --> Active, not recruiting Recruiting --> Completed
- Enrollment open: New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy (clinicaltrials.gov) - Jul 4, 2013
P=N/A, N=500, Recruiting, Sponsor: Shandong University
Recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Endoscopic Band Ligation Versus Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial (clinicaltrials.gov) - Jul 4, 2013
P3, N=30, Completed, Sponsor: University of Alberta
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment change: P-HDFL-DI: Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin (clinicaltrials.gov) - Jul 3, 2013
P2, N=29, Completed, Sponsor: National Taiwan University Hospital
Recruiting --> Completed N=40 --> 29
- Signifor (pasireotide) / Recordati
Trial completion: Study to Assess Safety and Efficacy of sc Pasireotide in Patients With Dumping Syndrome (clinicaltrials.gov) - Jul 3, 2013
P2, N=9, Completed, Sponsor: Universitaire Ziekenhuizen Leuven
N=40 --> 29 Not yet recruiting --> Completed
- Trial completion: P-HDFL-DI: Weekly Docetaxel/Irinotecan for Non-resectable Gastric Cancers After Cisplatin Plus 5-FU/Leucovorin (clinicaltrials.gov) - Jul 3, 2013
P2, N=29, Completed, Sponsor: National Taiwan University Hospital
Not yet recruiting --> Completed Recruiting --> Completed
- Istodax (romidepsin) / Astellas, BMS
Trial termination: FR901228 in Treating Patients With Refractory Stomach Cancer or Gastroesophageal Junction Cancer (clinicaltrials.gov) - Jun 30, 2013
P2, N=20, Terminated, Sponsor: National Cancer Institute (NCI)
Recruiting --> Completed Suspended --> Terminated
- pantoprazole / Generic mfg.
Trial initiation date: Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients. (clinicaltrials.gov) - Jun 30, 2013
P=N/A, N=198, Not yet recruiting, Sponsor: Rodrigo Cavallazzi
Suspended --> Terminated Initiation date: Mar 2013 --> Aug 2013
- 7-Hydroxystaurosporine (UCN-01) / National Cancer Institute
Trial completion: 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (clinicaltrials.gov) - Jun 30, 2013
P1, N=41, Completed, Sponsor: National Cancer Institute (NCI)
Initiation date: Mar 2013 --> Aug 2013 Active, not recruiting --> Completed
- ||| Clinical: Risk of Uncomplicated Peptic Ulcer in the General Population (clinicaltrials.gov) - Jun 26, 2013
P=N/A, N=4000, Completed, Sponsor: AstraZeneca
- |||| lansoprazole / Generic mfg.
Enrollment open: High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication (clinicaltrials.gov) - Jun 26, 2013
P4, N=118, Recruiting, Sponsor: Mahidol University
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| lansoprazole / Generic mfg.
New P4 trial: High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication (clinicaltrials.gov) - Jun 25, 2013
P4, N=118, Recruiting, Sponsor: Mahidol University
- | Zolinza (vorinostat) / Merck (MSD)
Trial completion, Metastases: Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer (clinicaltrials.gov) - Jun 25, 2013
P1, N=23, Completed, Sponsor: Roswell Park Cancer Institute
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- cisplatin / Generic mfg., capecitabine / Generic mfg., docetaxel / Generic mfg.
Trial completion, Surgery: DoCCS: A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer (clinicaltrials.gov) - Jun 24, 2013
P2, N=50, Completed, Sponsor: Jeroen Bosch Ziekenhuis
Active, not recruiting --> Completed Recruiting --> Completed
- oxaliplatin / Generic mfg., capecitabine / Generic mfg., docetaxel / Generic mfg.
Trial completion, Metastases: Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer (clinicaltrials.gov) - Jun 24, 2013
P2, N=56, Completed, Sponsor: Martin-Luther-Universit
Recruiting --> Completed Active, not recruiting --> Completed
- | BMS-833923 / BMS
Trial completion, Combination therapy, Metastases: A Study of BMS-833923 With Cisplatin and Capecitabine in Inoperable, Metastatic Gastric, Gastroesophageal, or Esophageal Adenocarcinomas (clinicaltrials.gov) - Jun 19, 2013
P1, N=39, Completed, Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Voquezna (vonoprazan) / Takeda, Phathom Pharma
Trial completion: Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric Ulcer (clinicaltrials.gov) - Jun 18, 2013
P3, N=482, Completed, Sponsor: Takeda Pharmaceutical Company Limited
Active, not recruiting --> Completed Recruiting --> Completed
- ||| aspirin / Generic mfg.
Trial completion: The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users (clinicaltrials.gov) - Jun 16, 2013
P=N/A, N=39000, Completed, Sponsor: AstraZeneca
Recruiting --> Completed Active, not recruiting --> Completed
- | fluorouracil topical / Generic mfg., cisplatin / Generic mfg., epirubicin / Generic mfg.
Trial completion: A Feasibility Study to Evaluate Adjuvant Chemoradiotherapy for Gastric Cancer (clinicaltrials.gov) - Jun 16, 2013
P3, N=52, Completed, Sponsor: Trans-Tasman Radiation Oncology Group (TROG)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||| Voquezna (vonoprazan) / Takeda, Phathom Pharma
Trial initiation date: Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin (clinicaltrials.gov) - Jun 13, 2013
P3, N=450, Recruiting, Sponsor: Takeda
Active, not recruiting --> Completed Initiation date: Sep 2011 --> Mar 2012
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka, Herceptin (trastuzumab) / Roche
Trial completion: A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer (clinicaltrials.gov) - Jun 13, 2013
P2, N=30, Completed, Sponsor: National Cancer Centre, Singapore
Initiation date: Sep 2011 --> Mar 2012 Recruiting --> Completed
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Trial termination: Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT (clinicaltrials.gov) - Jun 11, 2013
P1/2, N=30, Terminated, Sponsor: Samsung Medical Center
Recruiting --> Completed Recruiting --> Terminated; Difficulties in recruiting patients
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Enrollment change: Phase I/II Study of Neoadjuvant Chemoradiotherapy With S-1/ Oxaliplatin in Patients With Gastric Cancer: Randomized Phase II Study of S-1/RT vs. S-1/Oxaliplatin/RT (clinicaltrials.gov) - Jun 11, 2013
P1/2, N=30, Terminated, Sponsor: Samsung Medical Center
Recruiting --> Terminated; Difficulties in recruiting patients N=70 --> 30
- | oxaliplatin / Generic mfg., capecitabine / Generic mfg., docetaxel / Generic mfg.
New P2 trial: GastroDOC: Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer (clinicaltrials.gov) - Jun 11, 2013
P2, N=90, Recruiting, Sponsor: Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori
- Enrollment closed, Tumor cell: HER2 Circulating Tumor Cells in Gastric Cancer (clinicaltrials.gov) - Jun 11, 2013
P=N/A, N=200, Active, not recruiting, Sponsor: Samsung Medical Center
N=70 --> 30 Recruiting --> Active, not recruiting
- | simvastatin / Generic mfg., capecitabine / Generic mfg.
Enrollment closed, Metastases: Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients (clinicaltrials.gov) - Jun 11, 2013
P3, N=244, Active, not recruiting, Sponsor: Samsung Medical Center
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment change: Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (clinicaltrials.gov) - Jun 10, 2013
P=N/A, N=64, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Recruiting --> Active, not recruiting N=2000 --> 64
- Trial completion: Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors (clinicaltrials.gov) - Jun 10, 2013
P=N/A, N=64, Completed, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
N=2000 --> 64 Active, not recruiting --> Completed
- || Enrollment change: Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults (clinicaltrials.gov) - Jun 9, 2013
P1, N=113, Completed, Sponsor: Novartis Vaccines
Active, not recruiting --> Completed N=56 --> 113
- | emibetuzumab (LY2875358) / Eli Lilly, Innovent Biologics
New P2 trial, Metastases: A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer (clinicaltrials.gov) - Jun 9, 2013
P2, N=15, Recruiting, Sponsor: Eli Lilly and Company
- | Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
Trial initiation date: Rifaximin for Functional Dyspepsia (clinicaltrials.gov) - Jun 4, 2013
P2/3, N=90, Recruiting, Sponsor: The University of Hong Kong
N=56 --> 113 Initiation date: Sep 2012 --> Jan 2013
- Omegaven (omega-3 long-chain polyunsaturated fatty acids) / Fresenius Kabi
New P2 trial: Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer (clinicaltrials.gov) - Jun 4, 2013
P2, N=45, Recruiting, Sponsor: University Hospitals, Leicester
- | Xifaxan (rifaximin) / Alfa Wassermann, Bausch Health, Norgine, ASKA Pharma
Enrollment open: Rifaximin for Functional Dyspepsia (clinicaltrials.gov) - Jun 4, 2013
P2/3, N=90, Recruiting, Sponsor: The University of Hong Kong
Initiation date: Sep 2012 --> Jan 2013 Not yet recruiting --> Recruiting
- Omegaven (omega-3 long-chain polyunsaturated fatty acids) / Fresenius Kabi
Enrollment open: Study of Additive Omega-3 Fish Oil to Palliative Chemotherapy to Treat Oesophagogastric Cancer (clinicaltrials.gov) - Jun 2, 2013
P2, N=45, Recruiting, Sponsor: University Hospitals, Leicester
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| Avastin (bevacizumab) / Roche
Enrollment closed, Combination therapy, Metastases: A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer (clinicaltrials.gov) - Jun 2, 2013
P3, N=202, Active, not recruiting, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Enrollment change, Metastases: A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer (clinicaltrials.gov) - May 31, 2013
P1, N=6, Completed, Sponsor: Yonsei University
Recruiting --> Active, not recruiting N=12 --> 6
- clarithromycin / Generic mfg.
Trial completion: Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori (clinicaltrials.gov) - May 31, 2013
P4, N=180, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
N=12 --> 6 Recruiting --> Completed
- Trial completion, Surgery: Multi-institutional Study on the Assessment of Robotic Surgery for Gastric Cancer (clinicaltrials.gov) - May 31, 2013
P=N/A, N=1650, Completed, Sponsor: Yonsei University
Recruiting --> Completed Recruiting --> Completed
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Trial completion, Metastases: A Trial of Induction Chemotherapy and Chemoradiotherapy With TS-1 and Cisplatin (SP) as First-line Treatment in Patients With High Risk Advanced Gastric Cancer (clinicaltrials.gov) - May 31, 2013
P1, N=6, Completed, Sponsor: Yonsei University
Recruiting --> Completed Recruiting --> Completed
- ||| Gimoti (metoclopramide intranasal) / Evoke Pharma
Enrollment change: Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With Gastroparesis (clinicaltrials.gov) - May 27, 2013
P2, N=287, Completed, Sponsor: Evoke Pharma
Recruiting --> Completed N=225 --> 287